Researchers from the University of Bristol and the French National Centre for Scientific Research, teamed up with computer technology giant Oracle and vaccine innovator startup Imophoron to find a way to make vaccines that are thermostable, can be designed quickly, and are easily produced. “The research resulted in a new type of vaccine that can be stored at warmer temperatures, removing the need for refrigeration, in a major advance in vaccine technology.”